Covid Nasal Spray
- All
- News
- Videos
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
Nasal Spray Lowers Covid Viral Load By 94% In 24 Hours: Lancet Study
A nasal spray administered in high-risk adult Covid patients in India reduced viral load by 94% within 24 hours and 99% in 48 hours, according to the results of phase 3 trial of the drug published in The Lancet Regional Health Southeast Asia journal.
-
5-Point Guide To The New Nasal Spray For Covid Cleared By India
A nasal spray to treat adult COVID-19 patients has been launched in India after Mumbai-based developers Glenmark Pharmaceuticals received marketing clearances from the Drugs Controller General of India as part of an accelerated approval process.
-
First Nasal Spray For Treating Adult Covid Patients Launched In India
Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.
-
Looking Forward To "Second Generation" Of Covid Vaccines: WHO Chief Scientist
The World Health Organization's chief scientist said Tuesday she was looking forward to the "second generation" of Covid-19 vaccines, which could include nasal sprays and oral versions.
-
Nasal Spray Covid Vaccines May Be More Effective, In The Works: Experts
The Covid-19 vaccines closest to the finish line are designed to be injected into the arm. Researchers are looking at whether they can get better protection from inoculations that fight the virus at its point of attack - the nose and mouth.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
Nasal Spray Lowers Covid Viral Load By 94% In 24 Hours: Lancet Study
A nasal spray administered in high-risk adult Covid patients in India reduced viral load by 94% within 24 hours and 99% in 48 hours, according to the results of phase 3 trial of the drug published in The Lancet Regional Health Southeast Asia journal.
-
5-Point Guide To The New Nasal Spray For Covid Cleared By India
A nasal spray to treat adult COVID-19 patients has been launched in India after Mumbai-based developers Glenmark Pharmaceuticals received marketing clearances from the Drugs Controller General of India as part of an accelerated approval process.
-
First Nasal Spray For Treating Adult Covid Patients Launched In India
Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.
-
Looking Forward To "Second Generation" Of Covid Vaccines: WHO Chief Scientist
The World Health Organization's chief scientist said Tuesday she was looking forward to the "second generation" of Covid-19 vaccines, which could include nasal sprays and oral versions.
-
Nasal Spray Covid Vaccines May Be More Effective, In The Works: Experts
The Covid-19 vaccines closest to the finish line are designed to be injected into the arm. Researchers are looking at whether they can get better protection from inoculations that fight the virus at its point of attack - the nose and mouth.
